TriSalus Life Sciences   Report issue

For profit Phase 1
Founded: Westminster CO United States (2009)

Organization Overview

First Clinical Trial
2019
NCT04270929
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

TriSalus Life Sciences | TriSalus Life Sciences, Inc.